Difficulty: Medium
Average Score: 63%
Practice
Iron chelating agents are used for treatment of:
Correct answer
D
Rationale
Iron chelating agents are used for the treatment of chronic hemolytic anemia, which is characterized by the increased destruction of red blood cells leading to elevated levels of iron in the body. These agents help in removing the excess iron from the body, preventing iron overload which can lead to organ damage.
Option A) Leukemia: Leukemia is a type of cancer affecting the blood and bone marrow. Iron chelating agents are not indicated for the treatment of leukemia as the primary treatment involves chemotherapy, radiation, and bone marrow transplantation.
Option B) Lymphoma: Lymphoma is a cancer of the lymphatic system. Iron chelating agents are not used in the treatment of lymphoma as it is primarily managed with chemotherapy, radiation therapy, immunotherapy, or stem cell transplantation.
Option C) Wilms tumor: Wilms tumor is a type of kidney cancer that primarily affects children. Iron chelating agents are not part of the standard treatment for Wilms tumor, which typically involves surgery, chemotherapy, and sometimes radiation therapy.
Educationally, understanding the appropriate use of iron chelating agents in chronic hemolytic anemia is crucial for pediatric nurses. By knowing the indications for these agents, nurses can ensure proper administration, monitor for side effects, and educate patients and families on the importance of treatment compliance. This knowledge enhances the quality of care provided to pediatric patients with chronic hemolytic anemia.
Option A) Leukemia: Leukemia is a type of cancer affecting the blood and bone marrow. Iron chelating agents are not indicated for the treatment of leukemia as the primary treatment involves chemotherapy, radiation, and bone marrow transplantation.
Option B) Lymphoma: Lymphoma is a cancer of the lymphatic system. Iron chelating agents are not used in the treatment of lymphoma as it is primarily managed with chemotherapy, radiation therapy, immunotherapy, or stem cell transplantation.
Option C) Wilms tumor: Wilms tumor is a type of kidney cancer that primarily affects children. Iron chelating agents are not part of the standard treatment for Wilms tumor, which typically involves surgery, chemotherapy, and sometimes radiation therapy.
Educationally, understanding the appropriate use of iron chelating agents in chronic hemolytic anemia is crucial for pediatric nurses. By knowing the indications for these agents, nurses can ensure proper administration, monitor for side effects, and educate patients and families on the importance of treatment compliance. This knowledge enhances the quality of care provided to pediatric patients with chronic hemolytic anemia.